A vertically integrated, European cannabis company specializing in the cannabis value chain from seed to sale

Proven revenue ramp-up over the last 3 years. Generated over €11.5 million of sales revenue in 2021 with positive EBITDA

Currently undertaking research and innovation, product formulation, manufacturing, B-2-B international wholesale, sales and distribution of cannabis raw materials and derivative/finished products

Acquired 3,500 m2 facility with production capacity of up to 3.5 tons of high quality indoor flower per year

Specialized in cannabis and hemp breeding, propagation and production. Compiled one of Europe’s largest seedbanks

Import and export of raw material and bulk flowers (1kg upwards)

GACP certification is pending on the cultivation facility

Plan to upgrade to medical THC production and acquire EU GMP certification for drying, packaging, storage & distribution in 2023

Currently also undertaking B-2-B, B-2-C sales and e-commerce, retail and branding

Company controls a portfolio of leading European cannabis/CBD brands and has an extremely loyal client base

Successful business operations and marketing structure, e-commerce infrastructure, target focused in health and wellness/medicinal customers

Company also has a legal physical CBD store and selling its own recognized brands and products via top-ranked e-commerce store

The goal is to continue to expand in central Europe and globally, providing differentiated brands, quality and affordability of cannabis-based products

Managed by a highly experienced & diversified team of industry leaders with an entrepreneurial mindset, and a proven track record within the industry

Has exclusive partnerships across the value chain, including excellent relationships with regulatory authorities

The company is seeking €5 mill investment to further expand its operations and capture greater market share